IL6 and chronic kidney disease: Multiple randomized clinical trials and observational studies have shown that an omega-3 supplementation significantly reduces inflammatory biomarkers such as C-reactive protein (CRP), IL-6, and TNF-α in patients with CKD and heart failure [86,87,88].